Adult Urology: Voiding DysfunctionASSESSMENT OF COGNITIVE FUNCTION OF THE ELDERLY POPULATION: EFFECTS OF Darifenacin (cas 133099-04-4)
-
Add time:09/05/2019 Source:sciencedirect.com
ABSTRACTPurpose:Overactive bladder is common in the elderly population, which is susceptible to cognitive disorders and drug induced cognitive impairment. Existing overactive bladder treatments may cause adverse events, such as cognitive impairment, due to antagonism of the M1 receptor in the central nervous system. In this study we evaluated the effect of darifenacin, an M3 selective antagonist, on cognitive function in elderly volunteers without clinical dementia.
We also recommend Trading Suppliers and Manufacturers of Darifenacin (cas 133099-04-4). Pls Click Website Link as below: cas 133099-04-4 suppliers
Prev:Darifenacin (cas 133099-04-4)
Next:Adult Urology: Voiding DysfunctionINCREASED WARNING TIME WITH Darifenacin (cas 133099-04-4): A NEW CONCEPT IN THE MANAGEMENT OF URINARY URGENCY) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- ReviewDarifenacin (cas 133099-04-4), an M3 Selective Receptor Antagonist, is an Effective and Well-Tolerated Once-Daily Treatment for Overactive Bladder09/25/2019
- Female Urology—IncontinenceComparison of Darifenacin (cas 133099-04-4) and Oxybutynin in Patients with Overactive Bladder: Assessment of Ambulatory Urodynamics and Impact on Salivary Flow09/24/2019
- Neuro-urologyEffects of the M3 Receptor Selective Muscarinic Antagonist Darifenacin (cas 133099-04-4) on Bladder Afferent Activity of the Rat Pelvic Nerve09/10/2019
- Female Urology—IncontinenceTreatment of Overactive Bladder in the Older Patient: Pooled Analysis of Three Phase III Studies of Darifenacin (cas 133099-04-4), an M3 Selective Receptor Antagonist09/09/2019
- In vivo demonstration of M3 muscarinic receptor subtype selectivity of Darifenacin (cas 133099-04-4) in mice09/08/2019
- Neuro-urologyDifferential Effects of the Antimuscarinic Agents Darifenacin (cas 133099-04-4) and Oxybutynin ER on Memory in Older Subjects09/07/2019
- Adult Urology: Voiding DysfunctionINCREASED WARNING TIME WITH Darifenacin (cas 133099-04-4): A NEW CONCEPT IN THE MANAGEMENT OF URINARY URGENCY09/06/2019
- Darifenacin (cas 133099-04-4)09/04/2019
- Validated liquid chromatographic–fluorescence method for the quantitation of Darifenacin (cas 133099-04-4) in mice plasma and its application to a pharmacokinetic study09/03/2019
